Novavax, Inc. (NVAX) Reports In-Line Q1 EPS, Misses Revenue Expectations
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $834 thousand versus the consensus estimate of $2.29 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) Reiterated at Overweight by Cantor Fitzgerald
- Sensient Technologies (SXT) Tops Q3 EPS by 4c, Misses on Revenue; Offers FY26 EPS Guidance
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share